Simon A, Van Maanen E F
Arch Int Pharmacodyn Ther. 1976 Jul;222(1):4-15.
Phentolamine antagonized competitively the effects of noradrenaline (pA2 = 7.1), dopamine (pA2 = 8.0) and tyramine (pA2 = 8.2). Haloperidol had a pA2 value of 7.3 against dopamine and 6.5 against noradrenaline. Apomorphine antagonized competitively dopamine (pA 2 = 4.8) and tyramine (pA2 = 5.1) and noncompetitively antagonized noradrenaline (pD'2 = 3.6). From these data it is concluded that these antagonists interact with dopamine receptors and alpha-adrenergic receptors. Apomorphine (10-4 M) attenuated the maximal response to dopamine and field stimulation, whereas the same concentration of apomorphine potentiated the maximal response to noradrenaline. Assuming that tyramine and field stimulation release the naturally occurring neurohumoral transmitter from adrenergic nerve endings, it is concluded that dopamine is the physiologically functional neurohumoral transmitter in the rat vas deferens which, when released, stimulates specific dopamine receptors.
酚妥拉明竞争性拮抗去甲肾上腺素(pA2 = 7.1)、多巴胺(pA2 = 8.0)和酪胺(pA2 = 8.2)的作用。氟哌啶醇对多巴胺的pA2值为7.3,对去甲肾上腺素的pA2值为6.5。阿扑吗啡竞争性拮抗多巴胺(pA2 = 4.8)和酪胺(pA2 = 5.1),非竞争性拮抗去甲肾上腺素(pD'2 = 3.6)。从这些数据可以得出结论,这些拮抗剂与多巴胺受体和α-肾上腺素能受体相互作用。阿扑吗啡(10-4 M)减弱了对多巴胺和场刺激的最大反应,而相同浓度的阿扑吗啡增强了对去甲肾上腺素的最大反应。假设酪胺和场刺激从肾上腺素能神经末梢释放天然存在的神经体液递质,得出结论,多巴胺是大鼠输精管中生理功能上的神经体液递质,当其释放时,刺激特定的多巴胺受体。